I don't know if this will help you. I discovered this yesterday: It is a articel from * -> googel news: neuren pharma
“US$40 million will come to us when they make the first commercial sale and then they get awarded a rare paediatric disease priority review voucher which is tradeable and we get a third of whatever they sell it for,” he said.
https://unauthorised investment advice/health/why-all-eyes-are-on-neuren-pharmaceuticals-as-it-awaits-crucial-fda-approval-in-march/
Ann: Investor Presentation, 24 February 2023, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |